entertainment -WSS

entertainment

author：explore 2025-09-29 22:52:26 - browse：83986

Elf Bar disposable vape flavored vaping e-cigarette products are displayed in a convenience store. — The FDA is ramping up its efforts to force vape shops and other retailers to stop selling Elf Bar and Esco Bar products. PATRICK T. FALLON/AFP via Getty Images

WASHINGTON — The Food and Drug Administration is ramping up its efforts to force vape shops and other retailers to stop selling unauthorized disposable vape brands that are increasingly popular with young people.

The FDA recently issued 189 formal warning letters to shops selling two brands of vape products, Elf Bar and Esco Bars, the agency announced in a press release Thursday. The FDA has not authorized either brand, both of which are ubiquitous in gas stations and smoke shops around the country. They are therefore illegal to sell.

“This latest blitz should be a wake-up call for retailers of Elf Bar and Esco Bars products nationwide,” said Brian King, the head of the FDA’s tobacco center in a statement announcing the blitz.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： To avoid data mishandling cases, universities eye AI and other tools

WSS

The dental labor crisis is a moment of opportunity

Adopting new red light myopia treatments may be short

Biogen Alzheimer’s drug launch off to slow start

Biden report: The neurospychology of memory and aging

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

BioAge raises $170M for combination therapy with Zepbound

leisure time

entertainment

entertainment

Continuity nursing helped my family in our darkest PICU moments

A disappointing year of Humira biosimilars

Heart attack and stroke risk calculators need revising

Unique patient identifier: Experts argue the benefits, pitfalls

Supreme Court strikes down use of affirmative action

To avoid data mishandling cases, universities eye AI and other tools

Dobbs anniversary: the lost opportunity of abortion as health care

Biden report: The neurospychology of memory and aging

Moonlake's readout produced a cash windfall. Risks remain

KalVista pill reduced swelling 'attacks' caused by genetic disease

focus

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Private equity deals in Medicare Advantage declines

Why did Pfizer dish out millions for a Super Bowl ad?

A disappointing year of Humira biosimilars

Private equity deals in Medicare Advantage declines

340B reform proposal comes out of Senate working group

hotspot

knowledge

Wikipedia

focus